Whitepaper: Cubis® II pharma compliant by design
Posted: 6 June 2019 | Sartorius AG | No comments yet
Sartorius Cubis® II is designed to follow US FDA data integrity principles that require data to be accurate, legible, contemporaneous, original and attributable.
The Cubis® II balance series was designed for customizable modularity, which means the user can choose from many hardware and software options for thousands of different configurations. Choose from among 45 weighing modules, seven draft shields, two display and control units, and five software packages, including more than 60 software Apps.
Related content from this organisation
- Whitepaper: Phenotypic and functional CAR-T cell characterisation
- Sartorius releases the fifth edition of its popular Live-Cell Analysis Handbook
- An IgM antibody platform to tackle SARS-CoV-2 and its variants
- Whitepaper: Accelerate antibody screening and characterisation
- Whitepaper: Characterising astroglia models
Related topics
Assays, Drug Discovery Processes, Genomics, Stem Cells, Translational Science
Related organisations
Sartorius AG